Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer.
Eur J Cancer
; 75: 204-212, 2017 04.
Article
in En
| MEDLINE
| ID: mdl-28237866
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Capecitabine
/
Bevacizumab
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Eur J Cancer
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: